Merck’s pembrolizumab with berahyaluronidase alfa demonstrates noninferior PK compared to IV Keytruda in pivotal 3475A-D77 trial: Rahway, New Jersey Saturday, March 29, 2025, 10 ...

BNT327 combined with chemotherapy showed an overall response rate of 85.4% when used as a first-line treatment for ...

Context Therapeutics Inc. ("Context” or the "Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T ...

Developments in pedestrian safety and recreation moved forward this week in Albany while other proposed developments stalled. The first part of the week saw discussions about the future of Albany’s ...

Leap Therapeutics, Inc. , a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial results for the fourth quarter and year ended December 31, ...

"I was kind of surprised as well." Passerby awestruck after finding 'legendary' items in dumpster: 'Why would they just chuck ...

Leap to host a conference call to present updated CRC clinical data today, March 26, 2025, at 8:00 a.m. ET CAMBRIDGE, Mass., March 26, 2025 /PRNewswire/ -- Leap ...

Data from the ASCENT study of LIQ861 (YUTREPIA™) in PH-ILD patients highlights safety, tolerability, exploratory changes in six-minute walk ...

IV nutrition therapy is commonly used in medical settings but is gaining popularity in wellness circles. Learn the potential ...

AbbVie today announced that new data from its early oncology research will be showcased across multiple presentations at the upcoming American Association of Cancer Research (AACR) Annual Meeting, ...

Cleveland-Cliffs is laying off another 600 workers at a Detroit-area steel mill as automotive demand weakens. The steelmaker, ...

The group experienced a crash, then proceeded to heaven, and then to hell, where a demon flew down from a cable and knocked the pilot off a 20-foot stage drop onto a safety-padded landing amidst ...